• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主源性组织因子对肿瘤新生血管形成的作用。

Contribution of host-derived tissue factor to tumor neovascularization.

作者信息

Yu Joanne, May Linda, Milsom Chloe, Anderson G Mark, Weitz Jeffrey I, Luyendyk James P, Broze George, Mackman Nigel, Rak Janusz

机构信息

Henderson Research Centre, McMaster University, Hamilton, ON, Canada.

出版信息

Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1975-81. doi: 10.1161/ATVBAHA.108.175083. Epub 2008 Sep 4.

DOI:10.1161/ATVBAHA.108.175083
PMID:18772494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2848475/
Abstract

OBJECTIVE

The role of host-derived tissue factor (TF) in tumor growth, angiogenesis, and metastasis has hitherto been unclear and was investigated in this study.

METHODS AND RESULTS

We compared tumor growth, vascularity, and responses to cyclophosphamide (CTX) of tumors in wild-type (wt) mice, or in animals with TF levels reduced by 99% (low-TF mice). Global growth rate of 3 different types of transplantable tumors (LLC, B16F1, and ES teratoma) or metastasis were unchanged in low-TF mice. However, several unexpected tumor/context-specific alterations were observed in these mice, including: (1) reduced tumor blood vessel size in B16F1 tumors; (2) larger spleen size and greater tolerance to CTX toxicity in the LLC model; (3) aborted tumor growth after inoculation of TF-deficient tumor cells (ES TF(-/-)) in low-TF mice. TF-deficient tumor cells grew readily in mice with normal TF levels and attracted exclusively host-related blood vessels (without vasculogenic mimicry). We postulate that this complementarity may result from tumor-vascular transfer of TF-containing microvesicles, as we observed such transfer using human cancer cells (A431) and mouse endothelial cells, both in vitro and in vivo.

CONCLUSIONS

Our study points to an important but context-dependent role of host TF in tumor formation, angiogenesis and therapy.

摘要

目的

宿主源性组织因子(TF)在肿瘤生长、血管生成和转移中的作用迄今尚不清楚,本研究对此进行了探究。

方法与结果

我们比较了野生型(wt)小鼠或TF水平降低99%的动物(低TF小鼠)体内肿瘤的生长、血管形成以及对环磷酰胺(CTX)的反应。低TF小鼠体内3种不同类型可移植肿瘤(LLC、B16F1和ES畸胎瘤)的总体生长速率或转移情况未发生变化。然而,在这些小鼠中观察到了一些意外的肿瘤/背景特异性改变,包括:(1)B16F1肿瘤中肿瘤血管大小减小;(2)LLC模型中脾脏更大且对CTX毒性的耐受性更强;(3)在低TF小鼠中接种TF缺陷肿瘤细胞(ES TF(-/-))后肿瘤生长停止。TF缺陷肿瘤细胞在TF水平正常的小鼠中易于生长,并且仅吸引宿主相关血管(无血管生成拟态)。我们推测这种互补性可能源于含TF微泡的肿瘤-血管转移,因为我们在体外和体内使用人癌细胞(A431)和小鼠内皮细胞均观察到了这种转移。

结论

我们的研究指出宿主TF在肿瘤形成、血管生成和治疗中具有重要但依赖背景的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/548638341dd3/nihms126028f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/3611938b7326/nihms126028f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/c56f987a4dfa/nihms126028f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/c1cec75070f3/nihms126028f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/f34ec579e99f/nihms126028f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/548638341dd3/nihms126028f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/3611938b7326/nihms126028f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/c56f987a4dfa/nihms126028f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/c1cec75070f3/nihms126028f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/f34ec579e99f/nihms126028f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c308/2848475/548638341dd3/nihms126028f5.jpg

相似文献

1
Contribution of host-derived tissue factor to tumor neovascularization.宿主源性组织因子对肿瘤新生血管形成的作用。
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1975-81. doi: 10.1161/ATVBAHA.108.175083. Epub 2008 Sep 4.
2
Sharing tissue factor: a winning strategy in tumorigenesis.共享组织因子:肿瘤发生中的一种成功策略。
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1885-6. doi: 10.1161/ATVBAHA.108.176149.
3
Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.CD36--血小板反应蛋白--富含组氨酸糖蛋白轴在肿瘤血管生成和生长中的上下文相关作用。
PLoS One. 2012;7(7):e40033. doi: 10.1371/journal.pone.0040033. Epub 2012 Jul 10.
4
Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice.层粘连蛋白-8缺失导致小鼠肿瘤新生血管形成增加和转移。
Cancer Res. 2004 Jun 15;64(12):4059-63. doi: 10.1158/0008-5472.CAN-04-0291.
5
SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.SK-216,一种纤溶酶原激活物抑制剂-1 的抑制剂,可限制肿瘤进展和血管生成。
Mol Cancer Ther. 2013 Nov;12(11):2378-88. doi: 10.1158/1535-7163.MCT-13-0041. Epub 2013 Aug 29.
6
Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site.低水平的肿瘤坏死因子α通过诱导募集到肿瘤部位的单核细胞呈现内皮细胞表型来促进肿瘤生长。
Cancer Res. 2009 Jan 1;69(1):338-48. doi: 10.1158/0008-5472.CAN-08-1565.
7
Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296.血管内皮生长因子受体 2 抑制在体内以肿瘤类型依赖的方式影响肿瘤血管生成,并下调血管内皮生长因子受体 2 蛋白,而 miR-296 作用不明显。
Anticancer Drugs. 2012 Feb;23(2):161-72. doi: 10.1097/CAD.0b013e32834dc279.
8
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.通过抗体介导的内化作用靶向endosialin/CD248会导致周细胞成熟受损和肿瘤微血管功能失调。
Oncotarget. 2015 Sep 22;6(28):25429-40. doi: 10.18632/oncotarget.4559.
9
Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression.羽扇豆醇对小鼠黑色素瘤进展中血管生成拟态的逆转作用。
Microvasc Res. 2019 Jan;121:52-62. doi: 10.1016/j.mvr.2018.10.008. Epub 2018 Oct 25.
10
The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.肿瘤和宿主相关组织因子库在癌基因驱动的肿瘤进展中的作用。
Thromb Res. 2007;120 Suppl 2:S82-91. doi: 10.1016/S0049-3848(07)70135-4.

引用本文的文献

1
Vasculogenic mimicry-related gene prognostic index for predicting prognosis, immune microenvironment in clear cell renal cell carcinoma.用于预测透明细胞肾细胞癌预后及免疫微环境的血管生成拟态相关基因预后指数
Heliyon. 2024 Aug 14;10(16):e36235. doi: 10.1016/j.heliyon.2024.e36235. eCollection 2024 Aug 30.
2
Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma.血管生成拟态评分可识别肺腺癌的预后和免疫格局。
Front Genet. 2023 Jun 7;14:1206141. doi: 10.3389/fgene.2023.1206141. eCollection 2023.
3
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.

本文引用的文献

1
Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.用化疗药物长春新碱处理内皮细胞时,与成人血浆相比,新生儿血浆中活化蛋白C的生成受到的影响更大。
Thromb Res. 2008;122(3):418-26. doi: 10.1016/j.thromres.2007.12.003. Epub 2008 Feb 21.
2
Inhibition of tissue factor signaling suppresses tumor growth.抑制组织因子信号传导可抑制肿瘤生长。
Blood. 2008 Jan 1;111(1):190-9. doi: 10.1182/blood-2007-07-101048. Epub 2007 Sep 27.
3
Elevated tissue factor procoagulant activity in CD133-positive cancer cells.
癌症中的组织因子途径:硫酸乙酰肝素蛋白聚糖的概述及作用
Cancers (Basel). 2023 Feb 28;15(5):1524. doi: 10.3390/cancers15051524.
4
A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer.与人类胃癌免疫特征相关的血管生成拟态预后特征。
Front Immunol. 2022 Nov 23;13:1016612. doi: 10.3389/fimmu.2022.1016612. eCollection 2022.
5
Tinzaparin-a review of its molecular profile, pharmacology, special properties, and clinical uses.亭扎肝素——其分子特性、药理学、特殊性质和临床应用的综述。
Eur J Clin Pharmacol. 2022 Oct;78(10):1555-1565. doi: 10.1007/s00228-022-03365-4. Epub 2022 Jul 23.
6
Role of extracellular vesicles in tumour microenvironment.细胞外囊泡在肿瘤微环境中的作用。
Cell Commun Signal. 2020 Oct 20;18(1):163. doi: 10.1186/s12964-020-00643-5.
7
Procoagulant tumor microvesicles attach to endothelial cells on biochips under microfluidic flow.促凝血肿瘤微泡在微流控流动条件下附着于生物芯片上的内皮细胞。
Biomicrofluidics. 2019 Dec 6;13(6):064124. doi: 10.1063/1.5123462. eCollection 2019 Nov.
8
Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.组织因子与癌症:调控、肿瘤生长和转移。
Semin Thromb Hemost. 2019 Jun;45(4):385-395. doi: 10.1055/s-0039-1687894. Epub 2019 May 16.
9
Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and Treatments.外泌体、微颗粒和肿瘤小体介导的细胞间囊泡转运——对癌症生物学及治疗的影响
Front Oncol. 2019 Mar 6;9:125. doi: 10.3389/fonc.2019.00125. eCollection 2019.
10
Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.胶质瘤干细胞的分子亚型和分化程序作为细胞外囊泡谱和内皮细胞刺激活性的决定因素
J Extracell Vesicles. 2018 Jul 17;7(1):1490144. doi: 10.1080/20013078.2018.1490144. eCollection 2018.
CD133阳性癌细胞中组织因子促凝活性升高。
J Thromb Haemost. 2007 Dec;5(12):2550-2. doi: 10.1111/j.1538-7836.2007.02766.x. Epub 2007 Sep 19.
4
Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy.动脉粥样硬化和血管老化作为肿瘤进展、血管生成及治疗反应性的调节因素。
Am J Pathol. 2007 Oct;171(4):1342-51. doi: 10.2353/ajpath.2007.070298. Epub 2007 Sep 6.
5
Redundant signaling of tissue factor and thrombin in cancer progression?组织因子和凝血酶在癌症进展中的冗余信号传导?
J Thromb Haemost. 2007 Aug;5(8):1584-7. doi: 10.1111/j.1538-7836.2007.02622.x.
6
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.血液凝固外源性途径在止血和血栓形成中的作用。
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93. doi: 10.1161/ATVBAHA.107.141911. Epub 2007 Jun 7.
7
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition.血管生成抑制毒性中可能涉及的分子机制。
Nat Rev Cancer. 2007 Jun;7(6):475-85. doi: 10.1038/nrc2152.
8
Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.肿瘤细胞相关组织因子与循环止血因子通过自然杀伤细胞依赖和非依赖机制协同作用,以增加转移潜能。
Blood. 2007 Jul 1;110(1):133-41. doi: 10.1182/blood-2007-01-065995. Epub 2007 Mar 19.
9
CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models.CNTO 859是一种人源化抗组织因子单克隆抗体,在异种移植模型中是乳腺癌转移和肿瘤生长的有效抑制剂。
Int J Cancer. 2007 Mar 15;120(6):1261-7. doi: 10.1002/ijc.22426.
10
Mechanisms of cancer-induced thrombosis in cancer.癌症中癌症诱导血栓形成的机制
Pathophysiol Haemost Thromb. 2006;35(1-2):103-10. doi: 10.1159/000093551.